Despite $30-40 billion in enterprise investment into GenAI so far, “95% of organizations are seeing zero return.” Boards want ...
Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), ...
Jenny Quinn, executive director of the Seattle Universal Math Museum, shows off a solved Fibonacci sequence puzzle. (GeekWire Photo / Maddie Stoll) Jenny Quinn travels with math in her backpack. She ...